Sysmex Astrego AB

Sysmex Astrego AB is an in vitro diagnostic company based in Uppsala, Sweden. Founded in March 2017 and acquired by Sysmex Corporation in May 2022, the company focuses on combating antimicrobial resistance (AMR) through innovative diagnostic solutions. Its primary product is a rapid, automated Antibiotic Susceptibility Testing (AST) system that helps healthcare providers select effective antibiotic treatments, particularly for urinary tract infections (UTIs). The AST system is designed for fast, sensitive, and precise testing, suitable for both point-of-care and central laboratory settings. Sysmex Astrego aims to support healthcare providers and clinical laboratories with reliable diagnostic tools, ultimately improving patient outcomes and contributing to global health initiatives against AMR. The company is ISO 13485:2016 certified, ensuring a high standard of quality management in its operations.

• Employees 50
• Founded 2017